|
KOD
|
Kodiak Sciences Inc
|
0.04%
|
US
|
NASDAQ
|
|
TERN
|
Terns Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PETQ
|
PetIQ, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PAHC
|
Phibro Animal Health Corporation
|
0.03%
|
US
|
NASDAQ
|
|
OMGA
|
Omega Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MGTX
|
MeiraGTx Holdings plc
|
0.03%
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KNTE
|
Kinnate Biopharma Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
0.03%
|
US
|
NASDAQ
|
|
HROW
|
Harrow Health, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
HLTH
|
Cue Health Inc.
|
0.03%
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
0.03%
|
US
|
NASDAQ
|